Hsu PK, Pan FFC, Hsieh CS
In these cases, an individual's Medicare Part A coverage begins the later of 1) the month they turn 65 or 2) 6 months before the date that they apply for Medicare
These products are not medicines or drugs and have not been approved to prevent, treat or cure any medical condition, ailment or disease
This finding is consistent with the speculation that p53 is widely regarded as undruggable. Surprisingly, several novel therapeutic approaches targeting p53, including MDM2/4 antagonists, compounds that target specific p53 mutants or restore the wild-type function of the mutated p53 protein, p53-based genetic therapies and p53-based tumor immunotherapy, have been developed in recent years
The tolerability difference between these peptides is significant for sustained protocols